Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.
This study tests the hypothesis that addition of a protease-modulating matrix enhances the efficacy of autologous growth factors in diabetic ulcers. Fifty-one patients with chronic diabetic foot ulcers were managed as outpatients at the Democritus University Hospital of Alexandroupolis and followed up for 8 weeks. All target ulcers were > or = 2.5 cm in any one dimension and had been previously treated only with moist gauze. Patients were randomly allocated in three groups of 17 patients each: Group A was treated only with the oxidized regenerated cellulose/collagen biomaterial (Promogran, Johnson & Johnson, New Brunswick, NJ), Group B was treated only with autologous growth factors delivered by Gravitational Platelet Separation System (GPS, Biomet), and Group C was managed by a combination of both. All ulcers were digitally photographed at initiation of the study and then at change of dressings once weekly. Computerized planimetry (Texas Health Science Center ImageTool, Version 3.0) was used to assess ulcer dimensions that were analyzed for homogeneity and significance using the Statistical Package for Social Sciences, Version 13.0. Post hoc analysis revealed that there was significantly greater reduction of all three dimensions of the ulcers in Group C compared to Groups A and B (all P<.001). Although reduction of ulcer dimensions was greater in Group A than in Group B, these differences did not reach statistical significance. It is concluded that protease-modulating dressings act synergistically with autologous growth factors and enhance their efficacy in diabetic foot ulcers.
Kakagia
Despoina D
DD
1st Department of Surgery, Democritus University Hospital, Alexandroupolis, Greece. despoinakakagia@yahoo.com
Kazakos
Konstantinos J
KJ
Xarchas
Konstantinos C
KC
Karanikas
Michael
M
Georgiadis
George S
GS
Tripsiannis
Gregory
G
Manolas
Constantinos
C
D000368:Aged; D000704:Analysis of Variance; D001458:Bandages; D001672:Biocompatible Materials; D002482:Cellulose; D003094:Collagen / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement; D017719:Diabetic Foot / Q000473:pathology / Q000628:therapy*; D006133:Growth Substances / Q000502:physiology* / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D011446:Prospective Studies; D016896:Treatment Outcome; D014945:Wound Healing / Q000502:physiology*
D001672:Biocompatible Materials; D006133:Growth Substances; D002482:Cellulose; D003094:Collagen